Welcome to our dedicated page for Ge Healthcare Technologies SEC filings (Ticker: GEHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GE Healthcare鈥檚 latest 10-K tops 300 pages and is packed with details on MRI backlogs, contrast-agent regulations, and high-margin service contracts鈥攊nformation critical yet time-consuming to dissect. If you have ever searched for 鈥淕E Healthcare insider trading Form 4 transactions鈥� or wondered where the quarterly segment data hides, you know the challenge.
Stock Titan solves that problem. Our AI-powered summaries translate dense disclosures into plain language, flagging the numbers that matter and linking them to the exact page in the filing. Whether you need the 鈥淕E Healthcare quarterly earnings report 10-Q filing鈥� five minutes after it hits EDGAR or an alert on a sudden 鈥淕E Healthcare 8-K material events explained,鈥� you receive real-time updates plus expert context鈥攏o manual page flipping required.
Use our platform to:
- Track 鈥淕E Healthcare executive stock transactions Form 4鈥� in real time and spot buying or selling trends.
- Compare R&D spend across Imaging, Ultrasound, and Pharmaceutical Diagnostics without combing through footnotes.
- Understand the 鈥淕E Healthcare annual report 10-K simplified鈥� with AI-generated overviews, ratios, and red-flag alerts.
- Review the 鈥淕E Healthcare proxy statement executive compensation鈥� to see how leadership pay aligns with performance.
- Download every exhibit, amendment, and 鈥淕E Healthcare Form 4 insider transactions real-time鈥� feed in one place.
From cash-flow trends to device-approval milestones, our comprehensive coverage of all filing types鈥�10-K, 10-Q, 8-K, Form 4, S-8, and more鈥攇ives you the clarity needed to make informed decisions. Understanding GE Healthcare SEC documents with AI has never been this straightforward.
Kenneth R. Stacherski, an officer of GE HealthCare Technologies Inc. (GEHC), was awarded 10,217 restricted stock units (RSUs) on 08/15/2025. Each RSU converts to one share of GE HealthCare common stock at settlement. The award vests 50% on 08/15/2027 and 50% on 08/15/2028. Following the grant, the reporting person beneficially owns 41,888 shares. The Form 4 was signed by the company General Counsel as attorney-in-fact on 08/19/2025. No derivative transactions or cash purchase price were reported for this grant.
Dodge & Cox reports beneficial ownership of 23,567,950 shares of GE HealthCare Technologies, representing 5.1% of the company's common stock. The filing shows sole voting power for 22,284,487 shares and sole dispositive power for 23,567,950 shares. The reporting person is identified as an investment adviser (IA), and the filing states that Dodge & Cox clients have the right to receive dividends and proceeds from these securities. The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
FAQ
What is the current stock price of Ge Healthcare Technologies (GEHC)?
What is the market cap of Ge Healthcare Technologies (GEHC)?
